Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and laboratory management of the prothrombin G20210A mutation.

Archives of pathology & laboratory medicine - 1 Nov 2002

McGlennen Ronald C, Key Nigel S

Abstract excerpt

OBJECTIVE: To make recommendations regarding the appropriate evaluation for the prothrombin G20210A mutation, as reflected by published evidence and the consensus opinion of recognized experts in the field. DAT SOURCES: Review of the medical literature, primarily since 1996. DATA EXTRACTION AND SYNTHESIS: After an initial assessment of the literature, key points defining the condition, and review of the clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Practice Guidelines as Topic
Share to Pregnancy Complications, Hematologic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Prothrombin

Share to Risk Assessment

Share to Thromboembolism

Share to Thrombophilia

Share to Venous Thrombosis

Source

Identifiers

PMID: 12421139
DOI: 10.5858/2002-126-1319-CALMOT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and laboratory management of the prothrombin G20210A mutation.PMID 12421139Read ↗

Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.Semantic proximity Read ↗

Thrombophilias--practical implications and testing caveats.Semantic proximity Read ↗

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.Semantic proximity Read ↗

Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review.Semantic proximity Read ↗

What is the clinical relevance of the prothrombin G20210A mutation?Semantic proximity Read ↗

Management of antithrombin deficiency: an update for cliniciansSemantic proximity Read ↗

Management of inherited thrombophilia: guide for genetics professionals.Semantic proximity Read ↗

Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Semantic proximity Read ↗

Screening for thrombophilia: a laboratory perspective.Semantic proximity Read ↗

Role of the geneticist in testing and counseling for inherited thrombophilia.Semantic proximity Read ↗

Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.Semantic proximity Read ↗

Update on recognition and management of patients with acquired or inherited hypercoagulability.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.